|
MENTOR TEXAS MENTOR MEMORYGEL BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
|
Back to Search Results |
|
| Model Number |
3545590 |
| Medical Device Problem Codes |
Material Rupture (1546); Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Capsular Contracture (1761); Fluid Discharge (2686)
|
| Date of Event |
08/17/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: capsular contracture, peri-implant fluid.Explantation month, day, and year: (b)(6) 2023.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.Manufacturer¿s reference number: (b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that a 46-year-old caucasian female patient who underwent a primary breast augmentation procedure with mentor memorygel breast implant 535cc gel breast prostheses developed baker grade iii/iv capsular contracture in both of her breasts post implantation.Additionally, the patient developed peri-implant fluid in both breasts post implantation.As a result, the patient is scheduled to undergo bilateral explantation with no replacement breast prostheses on (b)(6) 2023.Pathology and cytology reports were requested.This medwatch report is for the patient¿s right breast prosthesis.
|
| |
|
Additional Manufacturer Narrative
|
|
On 15-jan-2024, the mentor failure analysis lab received the device for evaluation.Additionally, mentor became aware that the patient¿s right breast prosthesis ruptured post implantation.This medwatch report is for the patient¿s right breast prosthesis.On 22-jan-2024, mentor completed the investigation on the suspect medical device.Device evaluation summary: according to the information reported, the patient developed capsular contracture and peri-mplant fluid.Additionally, the breast prosthesis ruptured post implantation.The product was returned to mentor for evaluation.Mentor conducted a visual inspection of the returned device.Visual analysis of the returned sample determined that the breast implant was found to have a tear on the posterior view, measuring approximately 9.0 cm.As the authorization form for examination was not received the product evaluation lab couldn¿t identify a conclusion due to the specific nature of this rupture.The evaluation was limited to non-destructive testing.A manufacturing record evaluation was performed for the finished device batch number, and no non-conformances were identified.Although no conclusion could be reached on the cause of the reported event, the instructions for use contain the following caution: rupture can occur at any time after implantation, but it is more likely to occur the longer the implant is implanted.The following things may cause the implant to rupture: damage by surgical instruments; stressing the implant during implantation and weakening it; folding or wrinkling of the implant shell; excessive force to the chest (e.G.During closed capsulotomy); trauma; compression during mammographic imaging; and severe capsular contracture.Breast implants may also simply wear out over time.Mentor concluded that the capsular contracture in the patient¿s breast was the result of the body¿s individual physiological response to the implantation of a foreign object in soft tissue.Capsular contracture is a known complication associated with these devices and is referenced in our current product insert data sheet.The american society of plastic surgeons recommends and encourages member surgeons to always submit breast implants, capsule, and effusion to pathology for examination.As part of mentor¿s quality process, all devices are manufactured, inspected, and released to approved specifications.No corrective and preventive action (capa) is required now.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Manufacturer¿s reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|